U.S. Private Equity Stake In CMIC Shows Rosy Outlook For Japan's Contract Research Market
This article was originally published in PharmAsia News
Executive Summary
TOKYO - U.S. private equity firm Taiyo Pacific Partners secured a 5 percent stake in CMIC, Japan's largest CRO, highlighting the CRO market growth potential in Japan, despite increased focus on R&D outsourcing to China and India